Company Ticker News

Regeneron (REGN) Reports Positive Data on Antibody Cocktail

Regeneron (REGN) Reports Positive Data on Antibody Cocktail


ylliX - Online Advertising Network

Regeneron’s (REGN) phase III study assessing REGEN-COV in patients hospitalized with COVID-19 meets its primary goal.

...read full article on Zacks Investment Research